Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 3/20 | 0.61 |
| ▸ | CALCR | P30988 | 4/20 | 0.60 |
| ▸ | F2 | P00734 | 4/20 | 0.56 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | NMBR | P28336 | 1/20 | 0.52 |
| ▸ | GRPR | P30550 | 1/20 | 0.52 |
| ▸ | GLP1R | P43220 | 3/20 | 0.51 |
| ▸ | GCGR | P47871 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655882 | 0.97 | CALCR (0.60) | APLNRCALCRF2CRHR1CRHR2 | |
| SCHEMBL30432386 | 0.86 | F2 (0.62) | CALCRF2CRHR1CRHR2 | |
| SCHEMBL30495747 | 0.86 | APLNR (0.56) | APLNRCALCRF2CRHR1CRHR2 | |
| SCHEMBL30495842 | 0.85 | CALCR (0.62) | APLNRCALCRF2CRHR1CRHR2 | |
| SCHEMBL30431799 | 0.85 | CALCR (0.64) | APLNRCALCRCRHR1CRHR2GLP1R | |
| SCHEMBL30906485 | 0.85 | CALCR (0.67) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL29945130 | 0.85 | APLNR (0.67) | APLNRCALCRGLP1RGCGR | |
| SCHEMBL31514338 | 0.84 | APLNR (0.60) | APLNRCALCRF2GLP1RGCGR | |
| SCHEMBL31182920 | 0.83 | CALCR (0.71) | CALCRF2CRHR1CRHR2NMBR | |
| SCHEMBL29446768 | 0.83 | CALCR (0.58) | APLNRCALCRF2CRHR1CRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | claimed |
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2022-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344548-B2 | Analogs of 3,5-dihydroxypentanoate for bone formation | CYP24A1, CYP27B1, CYP2R1 | APLNR 1092/4885CALCR 189/4885F2 1872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.